New Ebola Drugs Experimented in DR Congo

Experimental Ebola Treatment proves successful

The Director-General of the DR Congos National Institute for Biomedical Research (INRB) Professor Jean-Jacques Muyembe, has said that a drug used for the first time on Ebola patients, the mAb114, is working well in North Kivu. It said it expects some patients to leave hospital on Tuesday August 21. Explaining in details, Prof. Muyembe said that 10 Ebola patients had received the drug in Beni and they are waiting for the Manufacturers in US to make more for them. According to a report from the WHO in Geneva, as of August 15th nearly 1,600 contacts including more than 120 health workers in North Kivu and Ituri provinces have been registered and are being followed up on a daily basis.